A Resident-led Initiative Improves Screening and Treatment for Vitamin D Deficiency in Patients with Hip Fractures
Background Acute hip fractures carry a high risk of morbidity and are associated with low vitamin D levels. Improvements in screening and treating low vitamin D levels may lead to lower fall rates and a lower likelihood of additional fragility fractures. However, patients with low vitamin D levels often remain unassessed and untreated, even after they experience these fractures. Questions/purposes We wished to determine whether a resident-led initiative can improve (1) screening for and (2) treatment of vitamin D deficiency in patients with acute hip fractures. Methods Our department initiated a housestaff-led, quality improvement project focused on screening and treating vitamin D deficiency in patients with acute hip fractures. Screening encompassed checking serum 25-hydroxyvitamin D level during the acute hospitalization, and treating was defined as starting supplementation before discharge when the serum 25-hydroxyvitamin D level was less than 30 ng/mL. To evaluate the efficacy of this program, an administrative database identified 283 patients treated surgically for an acute hip fracture between July 2010 and June 2014. This period included 2 years before program initiation (Year 1, n = 65 patients; Year 2, n = 61 patients), the initial program year (Year 3, n = 66 patients), and the subsequent program year (Year 4, n = 91 patients). Followup was extended to 6 weeks after treatment with 9.2% (26/282) of patients lost to followup. Eight patients were excluded owing to documented intolerance of vitamin D supplementation. There were no differences regarding patient demographics, fracture type, or treatment rendered across these 4 years. The primary endpoints were the proportion of patients screened and treated for vitamin D deficiency. The secondary endpoint was the continuation of vitamin D supplementation at the patient’s 6 week followup, according to the patient’s medication list at that visit. This analysis included all patients, assuming those lost to followup had not continued supplementation. ANOVA and chi-square tests were used to evaluate the differences in demographic data and in screening and treating rates. Results Screening for vitamin D deficiency improved after initiation of the resident-led quality improvement program, with screening performed for 31% of patients in Year 1 (20/65; odds ratio [OR], 0.44; 95% CI, 0.26–0.75), 20% of patients in Year 2 (12/61; OR, 0.24; 95% CI, 0.13–0.46), 46% of patients in Year 3 (30/66; OR, 0.83; 95% CI, 0.51–1.35), and 88% of patients in Year 4 (80/91; OR, 7.27; 95% CI, 3.87–13.7) (p < 0.001). Vitamin D supplementation was initiated for 33% of patients in Year 1 (21/63; OR, 0.5; 95% CI, 0.30–0.84), 28% in Year 2 (17/61; OR, 0.39; 95% CI, 0.22–0.68), 50% in Year 3 (32/64; OR,1.00; 95% CI, 0.61–1.63), and 76% in Year 4 (65/86; OR, 3.10; 95% CI, 1.89–5.06) (p < 0.001). At early postoperative followup, we saw substantial improvement in the proportion of patients who continued receiving vitamin D supplementation: Year 1, 12% (8/64; OR, 0.14; 95% CI, 0.07–0.30); Year 2, 15% (9/61; OR, 0.17; 95% CI, 0.09–0.35); Year 3, 26% (16/64; OR, 0.33; 95% CI, 0.19–0.59); and Year 4, 46% (40/86; OR, 0.87; 95% CI, 0.57–1.33) (p < 0.001). Conclusions Implementation of a resident-led quality improvement program resulted in higher rates of screening and treating vitamin D deficiency for patients with acute hip fractures. Housestaff-based initiatives may be an effective way to improve care processes that target improvements in bone health..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:475 |
---|---|
Enthalten in: |
Clinical orthopaedics and related research - 475(2016), 1 vom: 22. Aug., Seite 264-270 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lansdown, Drew A. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
BKL: | |
---|---|
Themen: |
Antimicrobial Stewardship Program |
doi: |
10.1007/s11999-016-5036-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
SPR023861053 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR023861053 | ||
003 | DE-627 | ||
005 | 20230519120307.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201006s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s11999-016-5036-4 |2 doi | |
035 | |a (DE-627)SPR023861053 | ||
035 | |a (SPR)s11999-016-5036-4-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q ASE |
084 | |a 44.83 |2 bkl | ||
100 | 1 | |a Lansdown, Drew A. |e verfasserin |4 aut | |
245 | 1 | 2 | |a A Resident-led Initiative Improves Screening and Treatment for Vitamin D Deficiency in Patients with Hip Fractures |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background Acute hip fractures carry a high risk of morbidity and are associated with low vitamin D levels. Improvements in screening and treating low vitamin D levels may lead to lower fall rates and a lower likelihood of additional fragility fractures. However, patients with low vitamin D levels often remain unassessed and untreated, even after they experience these fractures. Questions/purposes We wished to determine whether a resident-led initiative can improve (1) screening for and (2) treatment of vitamin D deficiency in patients with acute hip fractures. Methods Our department initiated a housestaff-led, quality improvement project focused on screening and treating vitamin D deficiency in patients with acute hip fractures. Screening encompassed checking serum 25-hydroxyvitamin D level during the acute hospitalization, and treating was defined as starting supplementation before discharge when the serum 25-hydroxyvitamin D level was less than 30 ng/mL. To evaluate the efficacy of this program, an administrative database identified 283 patients treated surgically for an acute hip fracture between July 2010 and June 2014. This period included 2 years before program initiation (Year 1, n = 65 patients; Year 2, n = 61 patients), the initial program year (Year 3, n = 66 patients), and the subsequent program year (Year 4, n = 91 patients). Followup was extended to 6 weeks after treatment with 9.2% (26/282) of patients lost to followup. Eight patients were excluded owing to documented intolerance of vitamin D supplementation. There were no differences regarding patient demographics, fracture type, or treatment rendered across these 4 years. The primary endpoints were the proportion of patients screened and treated for vitamin D deficiency. The secondary endpoint was the continuation of vitamin D supplementation at the patient’s 6 week followup, according to the patient’s medication list at that visit. This analysis included all patients, assuming those lost to followup had not continued supplementation. ANOVA and chi-square tests were used to evaluate the differences in demographic data and in screening and treating rates. Results Screening for vitamin D deficiency improved after initiation of the resident-led quality improvement program, with screening performed for 31% of patients in Year 1 (20/65; odds ratio [OR], 0.44; 95% CI, 0.26–0.75), 20% of patients in Year 2 (12/61; OR, 0.24; 95% CI, 0.13–0.46), 46% of patients in Year 3 (30/66; OR, 0.83; 95% CI, 0.51–1.35), and 88% of patients in Year 4 (80/91; OR, 7.27; 95% CI, 3.87–13.7) (p < 0.001). Vitamin D supplementation was initiated for 33% of patients in Year 1 (21/63; OR, 0.5; 95% CI, 0.30–0.84), 28% in Year 2 (17/61; OR, 0.39; 95% CI, 0.22–0.68), 50% in Year 3 (32/64; OR,1.00; 95% CI, 0.61–1.63), and 76% in Year 4 (65/86; OR, 3.10; 95% CI, 1.89–5.06) (p < 0.001). At early postoperative followup, we saw substantial improvement in the proportion of patients who continued receiving vitamin D supplementation: Year 1, 12% (8/64; OR, 0.14; 95% CI, 0.07–0.30); Year 2, 15% (9/61; OR, 0.17; 95% CI, 0.09–0.35); Year 3, 26% (16/64; OR, 0.33; 95% CI, 0.19–0.59); and Year 4, 46% (40/86; OR, 0.87; 95% CI, 0.57–1.33) (p < 0.001). Conclusions Implementation of a resident-led quality improvement program resulted in higher rates of screening and treating vitamin D deficiency for patients with acute hip fractures. Housestaff-based initiatives may be an effective way to improve care processes that target improvements in bone health. | ||
650 | 4 | |a Fragility Fracture |7 (dpeaa)DE-He213 | |
650 | 4 | |a Quality Improvement Program |7 (dpeaa)DE-He213 | |
650 | 4 | |a Quality Improvement Project |7 (dpeaa)DE-He213 | |
650 | 4 | |a Antimicrobial Stewardship Program |7 (dpeaa)DE-He213 | |
650 | 4 | |a Bone Health Treatment |7 (dpeaa)DE-He213 | |
700 | 1 | |a Whitaker, Amanda |e verfasserin |4 aut | |
700 | 1 | |a Wustrack, Rosanna |e verfasserin |4 aut | |
700 | 1 | |a Sawyer, Aenor |e verfasserin |4 aut | |
700 | 1 | |a Hansen, Erik N. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical orthopaedics and related research |d Philadelphia, PA : Wolters Kluwer Health, 1963 |g 475(2016), 1 vom: 22. Aug., Seite 264-270 |w (DE-627)SPR023542411 |w (DE-600)2018318-5 |x 1528-1132 |7 nnns |
773 | 1 | 8 | |g volume:475 |g year:2016 |g number:1 |g day:22 |g month:08 |g pages:264-270 |
856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11999-016-5036-4 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.83 |q ASE |
951 | |a AR | ||
952 | |d 475 |j 2016 |e 1 |b 22 |c 08 |h 264-270 |